199 related articles for article (PubMed ID: 38375508)
21. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
22. JAK/STAT3 regulated global gene expression dynamics during late-stage reprogramming process.
Wang L; Jiang Z; Huang D; Duan J; Huang C; Sullivan S; Vali K; Yin Y; Zhang M; Wegrzyn J; Tian XC; Tang Y
BMC Genomics; 2018 Mar; 19(1):183. PubMed ID: 29510661
[TBL] [Abstract][Full Text] [Related]
23. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.
Menendez JA; Vellon L; Oliveras-Ferraros C; Cufí S; Vazquez-Martin A
Cell Cycle; 2011 Nov; 10(21):3658-77. PubMed ID: 22052357
[TBL] [Abstract][Full Text] [Related]
24. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.
Schaefer T; Steiner R; Lengerke C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542
[TBL] [Abstract][Full Text] [Related]
25. The gene expression profiles of induced pluripotent stem cells (iPSCs) generated by a non-integrating method are more similar to embryonic stem cells than those of iPSCs generated by an integrating method.
Liu Y; Cheng D; Li Z; Gao X; Wang H
Genet Mol Biol; 2012 Jul; 35(3):693-700. PubMed ID: 23055811
[TBL] [Abstract][Full Text] [Related]
26. Regulatory factors of induced pluripotency: current status.
Zhao W; Ning B; Qian C
Stem Cell Investig; 2014; 1():15. PubMed ID: 27358861
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
28. Tinkering with transcription factors uncovers plasticity of somatic cells.
Azevedo JL; Feldman RA
Genes Cancer; 2010 Nov; 1(11):1089-99. PubMed ID: 21779433
[TBL] [Abstract][Full Text] [Related]
29. Acceleration of Mesenchymal-to-Epithelial Transition (MET) during Direct Reprogramming Using Natural Compounds.
Seo JH; Jang SW; Jeon YJ; Eun SY; Hong YJ; Do JT; Chae JI; Choi HW
J Microbiol Biotechnol; 2022 Oct; 32(10):1245-1252. PubMed ID: 36224763
[TBL] [Abstract][Full Text] [Related]
30. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.
Doege CA; Inoue K; Yamashita T; Rhee DB; Travis S; Fujita R; Guarnieri P; Bhagat G; Vanti WB; Shih A; Levine RL; Nik S; Chen EI; Abeliovich A
Nature; 2012 Aug; 488(7413):652-5. PubMed ID: 22902501
[TBL] [Abstract][Full Text] [Related]
31. Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs.
Kim JS; Choi HW; Araúzo-Bravo MJ; Schöler HR; Do JT
J Cell Sci; 2015 Jan; 128(1):81-7. PubMed ID: 25380819
[TBL] [Abstract][Full Text] [Related]
32. Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming.
Hu K
Cells; 2020 Nov; 9(11):. PubMed ID: 33203179
[TBL] [Abstract][Full Text] [Related]
33. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
[TBL] [Abstract][Full Text] [Related]
34. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.
Ishida T; Nakao S; Ueyama T; Harada Y; Kawamura T
Inflamm Regen; 2020; 40():8. PubMed ID: 32426078
[TBL] [Abstract][Full Text] [Related]
35. Context-dependent enhancement of induced pluripotent stem cell reprogramming by silencing Puma.
Lake BB; Fink J; Klemetsaune L; Fu X; Jeffers JR; Zambetti GP; Xu Y
Stem Cells; 2012 May; 30(5):888-97. PubMed ID: 22311782
[TBL] [Abstract][Full Text] [Related]
36. Identification of New Transcription Factors that Can Promote Pluripotent Reprogramming.
Huang P; Zhu J; Liu Y; Liu G; Zhang R; Li D; Pei D; Zhu P
Stem Cell Rev Rep; 2021 Dec; 17(6):2223-2234. PubMed ID: 34448118
[TBL] [Abstract][Full Text] [Related]
37. Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.
Hsu YC; Wu YT; Tsai CL; Wei YH
Exp Biol Med (Maywood); 2018 Mar; 243(6):563-575. PubMed ID: 29557214
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
[TBL] [Abstract][Full Text] [Related]
39. Influence of Cell Type in In Vitro Induced Reprogramming in Cattle.
Recchia K; Pessôa LVF; Pieri NCG; Pires PRL; Bressan FF
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013318
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
